Explore the parallels and differences between AI architectures and the human brain's design and functionality in processing ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Enterprise AI adoption looks strong, but real ROI lags. Why coordination theater, shadow IT and stalled redesign are distorting compounding value.
The World Economic Forum's Global Risks Report 2025 identified 7 of the top 10 long-term business risks as ESG-related.
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
New presentations for tildrakizumab-asmn explore real-world use in U.S. patients using Medicare New data specific to patients with skin of color expands ...
Opinion
The 'New World Order' and the media: Between power balances and the construction of perception
The debate surrounding the so-called “new international order” has persisted not because the concept lacks relevance, but because it resists simple definition.
Q2 2026 Earnings Call February 26, 2026 5:00 PM ESTCompany ParticipantsPaul Hughes - Joint Company SecretarySilviu Itescu ...
Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...
From the 1950s to 1970s, discovery of enzymes began by identifying new chemical reactions within cell-free extracts, but ...
In August 2024, I described how the advertising industry was entering the "walk" phase of artificial intelligence (AI) adoption. At that point, marketers had moved beyond experimentation. The early ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced full-year 2025 financial and operational highlights, including approximately $113 million in net product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results